The purpose of this study is to evaluate the effects of freeze dried strawberry powder on LDL cholesterol, central and peripheral blood pressure, indices of arterial stiffness, and other lipid and lipoprotein concentrations. The investigators hypothesize that the bioactive compounds in freeze dried strawberry powder may elicit beneficial effects on LDL cholesterol, as well as blood pressure and arterial health.
The proposed study design is a 3-period randomized crossover dose-response study to evaluate the effect of freeze dried strawberry powder supplementation on LDL-C and vascular health. Research participants will be overweight or obese (BMI 25-39 kg/m\^2) but otherwise healthy adults with moderately elevated LDL-C (\>116 mg/dL or \>3.0mmol/L), blood pressure \<160/100 mmHg, total cholesterol below 273 mg/dL for men and below 284 mg/dL for women, and triglycerides below 350 mg/dL. Subjects will be randomly assigned to three supplementation periods: 1) low dose freeze dried strawberry powder (13 g/d); 2) high dose freeze dried strawberry powder (40 g/d); and 3) a placebo powder. Each powder will be provided for 4-6 weeks, separated by a 2-week washout period between treatment periods. Baseline and endpoint testing will include blood collection and vascular testing.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
42
40 g composed of 13 g freeze dried strawberry powder + 27 g placebo powder
40 g freeze dried strawberry powder
40 g color and taste matched placebo powder
Penn State CRC
University Park, Pennsylvania, United States
LDL-C
LDL-C values calculated using the Friedewald equation
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
Central Blood Pressure
Aortic (central) blood pressure measured using the SphygmoCor System
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
Peripheral Blood Pressure
Peripheral blood pressure measured using the SphygmoCor System
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
Augmentation Index
Augmentation index measured using the SphygmoCor System
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
Pulse Wave Velocity
Pulse wave velocity measured using the SphygmoCor System
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
Total Cholesterol
Total cholesterol values determined by enzymatic procedures
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
Triglycerides
Triglyceride values determined using enzymatic procedures
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
HDL-C
HDL-C will be estimated according to the modified heparin-manganese procedure
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
Oxidized LDL (oxLDL)
Plasma concentrations of oxLDL will be measured using ELISA kits
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
Malondialdehyde (MDA)
MDA will be measured using the thiobarbituric acid reactive substances (TBARS) assay
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage
High Sensitivity C Reactive Protein (hs-CRP)
hs-CRP will be measured by latex-enhanced immunonephelometry
Time frame: Change from baseline after 4 week treatments of low dose, high dose, and placebo strawberry beverage